Phelan Suzanne, Kanaya Alka M, Ma Yong, Vittinghoff Eric, Barrett-Connor Elizabeth, Wing Rena, Kusek John W, Orchard Trevor J, Crandall Jill P, Montez Maria G, Brown Jeanette S
Kinesiology Department, California Polytechnic State University, San Luis Obispo, California, USA.
Int J Urol. 2015 Feb;22(2):206-12. doi: 10.1111/iju.12654. Epub 2014 Oct 28.
To examine the long-term prevalence and predictors of weekly urinary incontinence in the Diabetes Prevention Program Outcomes Study, a follow-up study of the Diabetes Prevention Program randomized clinical trial of overweight adults with impaired glucose tolerance.
This analysis included 1778 female participants of the Diabetes Prevention Program Outcomes Study who had been randomly assigned during the Diabetes Prevention Program to intensive lifestyle intervention (n = 582), metformin (n = 589) or placebo (n = 607). The study participants completed semi-annual assessments after the final Diabetes Prevention Program visit and for 6 years until October 2008.
At the study entry, the prevalence of weekly urinary incontinence was lower in the intensive lifestyle intervention group compared with the metformin and placebo groups (44.2% vs 51.8%, 48.0% urinary incontinence/week, P = 0.04); during the 6-year follow-up period, these lower rates in intensive lifestyle intervention were maintained (46.7%, 53.1%, 49.9% urinary incontinence/week; P = 0.03). Statistically adjusting for urinary incontinence prevalence at the end of the Diabetes Prevention Program, the treatment arm no longer had a significant impact on urinary incontinence during the Diabetes Prevention Program Outcomes Study. Independent predictors of lower urinary incontinence during the Diabetes Prevention Program Outcomes Study included lower body mass index (odds ratio 0.988, 95% confidence interval 0.982-0.994) and greater physical activity (odds ratio 0.999, 95% confidence interval 0.998-1.000) at the Diabetes Prevention Program Outcomes Study entry, and greater reductions in body mass index (odds ratio 0.75, 95% confidence interval 0.60-0.94) and waist circumference (odds ratio 0.998, 95% confidence interval 0.996-1.0) during the Diabetes Prevention Program Outcomes Study. Diabetes was not significantly related to urinary incontinence.
Intensive lifestyle intervention has a modest positive and enduring impact on urinary incontinence, and should be considered for the long-term prevention and treatment of urinary incontinence in overweight/obese women with glucose intolerance.
在糖尿病预防计划结局研究中,对超重且糖耐量受损的成年人进行糖尿病预防计划随机临床试验的后续研究,以检查每周尿失禁的长期患病率及预测因素。
该分析纳入了糖尿病预防计划结局研究中的1778名女性参与者,她们在糖尿病预防计划期间被随机分配至强化生活方式干预组(n = 582)、二甲双胍组(n = 589)或安慰剂组(n = 607)。研究参与者在糖尿病预防计划最后一次访视后每半年进行一次评估,并持续6年直至2008年10月。
在研究开始时,强化生活方式干预组每周尿失禁的患病率低于二甲双胍组和安慰剂组(44.2% 对51.8%,每周尿失禁发生率为48.0%,P = 0.04);在6年随访期内,强化生活方式干预组的较低发生率得以维持(每周尿失禁发生率分别为46.7%、53.1%、49.9%;P = 0.03)。在对糖尿病预防计划结束时的尿失禁患病率进行统计学调整后,治疗组在糖尿病预防计划结局研究期间对尿失禁不再有显著影响。糖尿病预防计划结局研究期间尿失禁发生率较低的独立预测因素包括:在糖尿病预防计划结局研究开始时较低的体重指数(比值比0.988,95%置信区间0.982 - 0.994)和较高的身体活动水平(比值比0.999,95%置信区间0.998 - 1.000),以及在糖尿病预防计划结局研究期间体重指数(比值比0.75,95%置信区间0.60 - 0.94)和腰围(比值比0.998,95%置信区间0.996 - 1.0)的更大降幅。糖尿病与尿失禁无显著相关性。
强化生活方式干预对尿失禁有适度的积极且持久的影响,对于超重/肥胖且糖耐量受损的女性,应考虑将其用于尿失禁的长期预防和治疗。